Characterization of Inflammatory Signals in BV-2 Microglia in Response to Wnt3a

Area of Science:

• Neuroscience
• Immunology
• Cell Biology

Background:

• Microglial activation is central to neuroinflammation and associated central nervous system diseases.
• Inhibiting microglial inflammatory activation offers a therapeutic strategy for neuroinflammation.

Purpose of the Study:

• To investigate the effect of Wnt/β-catenin signaling pathway activation on neuroinflammation.
• To determine if Wnt/β-catenin activation can inhibit the production of key inflammatory mediators.

Main Methods:

• Utilized a cell model of neuroinflammation using Lipopolysaccharide (LPS)/IFN-γ-stimulated BV-2 cells.
• Analyzed the impact of Wnt/β-catenin pathway activation on nitric oxide (NO), interleukin-6 (IL-6), and tumor necrosis factor-α (TNF-α) production.
• Assessed the modulation of nuclear factor-κB (NF-κB) and extracellular signal-regulated kinase (ERK) phosphorylation.

Main Results:

• Wnt/β-catenin pathway activation inhibited the production of NO, IL-6, and TNF-α in LPS/IFN-γ-stimulated BV-2 cells.
• Pathway activation suppressed the phosphorylation of NF-κB and ERK.
• Demonstrated downregulation of pro-inflammatory cytokines (iNOS, TNF-α, IL-6) and NF-κB/ERK signaling.

Conclusions:

• Wnt/β-catenin signaling activation effectively inhibits neuroinflammation.
• This pathway modulates key inflammatory mediators and signaling cascades.
• Wnt/β-catenin activation presents a potential therapeutic target for neuroprotection in neuroinflammatory diseases.